Disorders of selenium metabolism and selenoprotein function

Current Opinion in Pediatrics

Volumn 23, Issue 4, 2011, Pages 429-435

  Schweizer, Ulrich ^a   Dehina, Nora ^a   Schomburg, Lutz ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

genetic defect; nutrition; supplementation; trace element; translation

Indexed keywords

GLUTATHIONE PEROXIDASE 1; PEROXIDE; SELENIUM; SELENOCYSTEINE; SELENOPROTEIN;

BIOSYNTHESIS; BONE DEVELOPMENT; CANCER RISK; CARDIOMYOPATHY; CHRONIC DISEASE; CONGENITAL HYPOTHYROIDISM; COXSACKIE VIRUS; DEGRADATION KINETICS; DEVELOPMENTAL DISORDER; DIET SUPPLEMENTATION; GENE INSERTION SEQUENCE; GROWTH RETARDATION; HUMAN; INFLAMMATION; INTOXICATION; KASHIN BECK DISEASE; KESHAN DISEASE; MALE INFERTILITY; MAMMAL CELL; MENTAL DEFICIENCY; MOLECULAR BIOLOGY; MUSCLE FUNCTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGRESSIVE CEREBELLO CEREBRAL ATROPHY; PROTEIN FUNCTION; REDOX STRESS; REVIEW; SECISBP2 SYNDROME; SELENIUM DEFICIENCY; THYROID FUNCTION;

HUMANS; METABOLISM, INBORN ERRORS; MUSCLE, SKELETAL; SELENIUM; SELENOPROTEINS; THYROID GLAND;

EID: 79960848129     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0b013e32834877da     Document Type: Review

References (69)

1. Weber GF, Maertens P, Meng XZ, Pippenger CE. Glutathione peroxidase deficiency and childhood seizures. Lancet 1991; 337:1443-1444.
2. Ramaekers VT, Calomme M, Vanden Berghe D, Makropoulos W. Selenium deficiency triggering intractable seizures. Neuropediatrics 1994; 25:217-223. (Pubitemid 24304611)
3. Beutler E, Curnutte JT, Forman L Glutathione peroxidase deficiency and childhood seizures. Lancet 1991; 338:700.
4. Bock A, Forchhammer K, Heider J, Baron C. Selenoprotein synthesis: an expansion of the genetic code. Trends Biochem Sci 1991; 16:463-467. (Pubitemid 121004494)
5. Flohe L. The labour pains of biochemical selenology: the history of seleno-protein biosynthesis. Biochim Biophys Acta 2009; 1790:1389-1403.
6. Hatfield DL, Gladyshev VN. How selenium has altered our understanding of the genetic code. Mol Cell Biol 2002; 22:3565-3576. (Pubitemid 34525202)
7. Lobanov AV, Hatfield DL, Gladyshev VN. Eukaryotic selenoproteins and selenoproteomes. Biochim Biophys Acta 2009; 1790:1424-1428.
8. Kryukov GV, Castellano S, Novoselov SV, et al. Characterization of mammalian selenoproteomes. Science 2003; 300:1439-1443. (Pubitemid 36638165)
9. Flohe L, Gunzler WA, Schock HH. Glutathione peroxidase: a selenoenzyme. FEBS Lett 1973; 32:132-134.
10. Rotruck JT, Pope AL, Ganther HE, et al. Selenium: biochemical role as a component of glutathione peroxidase. Science 1973; 179:588-590.
11. Seiler A, Schneider M, Forster H, et al. Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab 2008; 8:237-248.
12. Berry MJ, Banu L, Chen YY, et al. Recognition of UGA as a selenocysteine codon in type I deiodinase requires sequences in the 3' untranslated region. Nature 1991; 353:273-276. (Pubitemid 21896772)
13. Schweizer U, Weitzel JM, Schomburg L. Think globally: act locally. New insights into the local regulation of thyroid hormone availability challenge long accepted dogmas. Mol Cell Endocrinol 2008; 289:1-9.
14. Kim HY, Gladyshev VN. Different catalytic mechanisms in mammalian selenocysteine- and cysteine-containing methionine-R-sulfoxide reductases. PLoS Biol 2005; 3:e375.
15. Shchedrina VA, Zhang Y, Labunskyy VM, et al. Structure-function relations, physiological roles, and evolution of mammalian ER-resident selenoproteins. Antioxid Redox Signal 2010; 12:839-849.
16. Curran JE, Jowett JB, Elliott KS, et al. Genetic variation in selenoprotein S influences inflammatory response. Nat Genet 2005; 37:1234-1241. (Pubitemid 41568706)
17. Burk RF, Hill KE. Selenoprotein P:an extracellular protein with unique physical characteristics and a role in selenium homeostasis. Annu Rev Nutr 2005; 25:215-235. (Pubitemid 41209001)
18. Schomburg L, Schweizer U, Holtmann B, et al. Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues. Biochem J 2003; 370:397-402. (Pubitemid 36315127)
19. Schomburg L, Schweizer U. Hierarchical regulation of selenoprotein expression and sex-specific effects of selenium. Biochim Biophys Acta 2009; 1790:1453-1462.
20. Schweizer U, Michaelis M, Kohrle J, Schomburg L Efficient selenium transfer from mother to offspring in selenoprotein-P-deficient mice enables dose-dependent rescue of phenotypes associated with selenium deficiency. Biochem J 2004; 378:21-26. (Pubitemid 38299540)
21. Hill KE, Zhou J, McMahan WJ, et al. Neurological dysfunction occurs in mice with targeted deletion of the selenoprotein P gene. J Nutr 2004; 134:157-161. (Pubitemid 38057440)
22. Conrad M, Schweizer U. Unveiling the molecular mechanisms behind selenium-related diseases through knockout mouse studies. Antioxid Redox Signal 2010; 12:851-865.
23. Schweizer U, Streckfuss F, Pelt P, et al. Hepatically derived selenoprotein Pis a key factor for kidney but not for brain selenium supply. Biochem J 2005; 386:221-226.
24. Carlson BA, Yoo MH, Sano Y, et al. Selenoproteins regulate macrophage invasiveness and extracellular matrix-related gene expression. BMC Immunol 2009; 10:57.
25. Shrimali RK, Irons RD, Carlson BA, et al. Selenoproteins mediate T cell immunity through an antioxidant mechanism. J Biol Chem 2008; 283:201 81-20185.
26. Wirth EK, Conrad M, Winterer J, et al. Neuronal selenoprotein expression is required for interneuron development and prevents seizures and neurode-generation. FASEB J 2010; 24:844-852.
27. Hatfield DL, Yoo MH, Carlson BA, Gladyshev VN. Selenoproteins that function in cancer prevention and promotion. Biochim Biophys Acta 2009; 1790:1541-1545.
28. Zhuo P, Diamond AM. Molecular mechanisms by which selenoproteins affect cancer risk and progression. Biochim Biophys Acta 2009; 1790:1546-1554.
29. Renko K, Hofmann PJ, Stoedter M, et al. Down-regulation of the hepatic selenoprotein biosynthesis machinery impairs selenium metabolism during the acute phase response in mice. FASEB J 2009; 23:1758-1765.
30. Kohrle J, Jakob F, Contempre B, Dumont JE. Selenium, the thyroid, and the endocrine system. Endocr Rev 2005; 26:944-984. (Pubitemid 41770159)
31. Diamond AM, Jaffe D, Murray JL, et al. Lovastatin effects on human breast carcinoma cells. Differential toxicity of an adriamycin-resistant derivative and influence on selenocysteine t RNAS. Biochem Mol Biol Int 1996; 38:345-355. (Pubitemid 26258433)
32. Handy DE, Hang G, Scolaro J, et al. Aminoglycosides decrease glutathione peroxidase-1 activity by interfering with selenocysteine incorporation. J Biol Chem 2006; 281:3382-3388. (Pubitemid 43845952)
33. Moghadaszadeh B, Petit N, Jaillard C, et al. Mutations in SEPN1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome. Nat Genet 2001; 29:17-18. (Pubitemid 32801799)
34. Ferreiro A, Quijano-Roy S, Pichereau C, et al. Mutations of the selenoprotein N gene, which is implicated in rigid spine muscular dystrophy, cause the classical phenotype of multiminicore disease: reassessing the nosology of early-onset myopathies. Am J Hum Genet 2002; 71:739-749. (Pubitemid 135750508)
35. Allamand V, Richard P, Lescure A, et al. A single homozygous point mutation in a 3' untranslated region motif of selenoprotein N m RNA causes SEPN1-related myopathy. EMBO Rep 2006; 7:450-454.
36. Jurynec MJ, Xia R, Mackrill JJ, et al. Selenoprotein N is required for ryanodine receptor calcium release channel activity in human and zebrafish muscle. Proc Natl Acad Sci USA 2008; 105:12485-12490.
37. Muth OH, Oldfield JE, Remmert LF, Schubert JR. Effects of selenium and vitamin E on white muscle disease. Science 1958; 128:1090.
38. Brown MR, Cohen HJ, Lyons JM, et al. Proximal muscle weakness and selenium deficiency associated with long term parenteral nutrition. Am J Clin Nutr 1986; 43:549-554. (Pubitemid 16014844)
39. Ge K, Xue A, Bai J, Wang S. Keshan disease: an endemic cardiomyopathy in China. Virchows Arch A Pathol Anat Histopathol 1983; 401:1-15. (Pubitemid 13035171)
40. Beck MA. Rapid genomic evolution of a nonvirulent coxsackievirus B3 in selenium-deficient mice. Biomed Environ Sci 1997; 10:307-315. (Pubitemid 127472093)
41. Beck MA, Shi Q, Morris VC, Levander OA. Rapid genomic evolution of a nonvirulent coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates. Nat Med 1995; 1:433-436.
42. Beck MA, Esworthy RS, Ho YS, Chu FF. Glutathione peroxidase protects mice from viral-induced myocarditis. FASEB J 1998; 12:1143-1149. (Pubitemid 28418944)
43. Conrad M, Jakupoglu C, Moreno SG, et al. Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development, and heart function. Mol Cell Biol 2004; 24:9414-9423. (Pubitemid 39391679)
44. Sibbing D, Pfeufer A, Perisic T, et al. Mutations in the mitochondrial thioredoxin reductase gene TXNRD2 cause dilated cardiomyopathy. Eur Heart J 2011; 32:1121-1133.
45. Blankenberg S, Rupprecht HJ, Bickel C, et al. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med 2003; 349:1605-1613. (Pubitemid 37288568)
46. Neve J. Selenium as a risk factor for cardiovascular diseases. J Cardiovasc Risk 1996; 3:42-47. (Pubitemid 26184617)
47. Dickson RC, Tomlinson RH. Selenium in blood and human tissues. Clin Chim Acta 1967; 16:311-321.
48. Schomburg L, Riese C, Michaelis M, et al. Synthesis and metabolism of thyroid hormones is preferentially maintained in selenium-deficient transgenic mice. Endocrinology 2006; 147:1306-1313. (Pubitemid 43244364)
49. Schweizer U, Chiu J, Kohrle J. Peroxides and peroxide-degrading enzymes in the thyroid. Antioxid Redox Signal 2008; 10:1577-1592. (Pubitemid 351931931)
50. Dumont JE, Corvilain B, Contempre B. The biochemistry of endemic cretinism: roles of iodine and selenium deficiency and goitrogens. Mol Cell Endocrinol 1994; 100:163-166. (Pubitemid 24109545)
51. Chanoine JP, Safran M, Farwell AP, et al. Effects of selenium deficiency on thyroid hormone economy in rats. Endocrinology 1992; 131:1787-1792.
52. Ng L, Goodyear RJ, Woods CA, et al. Hearing loss and retarded cochlear development in mice lacking type 2 iodothyronine deiodinase. Proc Natl Acad Sci USA 2004; 101:3474-3479. (Pubitemid 38338219)
53. Ng L, Hernandez A, He W, et al. A protective role for type 3 deiodinase, a thyroid hormone-inactivating enzyme, in cochlear development and auditory function. Endocrinology 2009; 150:1952-1960.
54. Ng L, Lyubarsky A, Nikonov SS, et al. Type 3 deiodinase, a thyroid-hormone-inactivating enzyme, controls survival and maturation of cone photoreceptors. J Neurosci 2010; 30:3347-3357.
55. Bassett JH, Boyde A, Howell PG, et al. Optimal bone strength and mineralization requires the type 2 iodothyronine deiodinase in osteoblasts. Proc Natl Acad Sci USA 2010; 107:7604-7609.
56. Downey CM, Horton CR, Carlson BA, et al. Osteo-chondroprogenitor-specific deletion of the selenocysteine t RNA gene, Trsp, leads to chondro-necrosis and abnormal skeletal development: a putative model for Kashin-Beck disease. PLoS Genet 2009; 5:e1 000616.
57. Dumitrescu AM, Liao XH, Abdullah MS, et al. Mutations in SECISBP2 result in abnormal thyroid hormone metabolism. Nat Genet 2005; 37:1247-1252.
58. Dumitrescu AM, Di Cosmo C, Liao XH, et al. The syndrome of inherited partial SBP2 deficiency in humans. Antioxid Redox Signal 2010; 12:905-920.
59. Azevedo MF, Barra GB, Naves LA, et al. Selenoprotein-related disease in a young girl caused by nonsense mutations in the SBP2 gene. J Clin Endocrinol Metab 2010; 95:4066-4071.
60. Schoenmakers E, Agostini M, Mitchell C, et al. Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans. J Clin Invest 2010; 120:4220-4235.
61. Renko K, Werner M, Renner-Muller I, et al. Hepatic selenoprotein P (Se PP) expression restores selenium transport and prevents infertility and motor-incoordination in Sepp-knockout mice. Biochem J 2008; 409:741-749. (Pubitemid 351214200)
62. Bosl MR, Takaku K, Oshima M, et al. Early embryonic lethality caused by targeted disruption of the mouse selenocysteine t RNA gene (Trsp). Proc Natl Acad Sci U S A 1997; 94:5531-5534. (Pubitemid 27241803)
63. Schomburg L, Dumitrescu AM, Liao XH, et al. Selenium supplementation fails to correct the selenoprotein synthesis defect in subjects with SBP2 gene mutations. Thyroid 2009; 19:277-281.
64. Agamy O, Ben Zeev B, Lev D, et al. Mutations disrupting selenocysteine formation cause progressive cerebello-cerebral atrophy. Am J Hum Genet 2010; 87:538-544.
65. Ben-Zeev B, Hoffman C, Lev D, et al. Progressive cerebellocerebral atrophy: a new syndrome with microcephaly, mental retardation, and spastic quadriplegia. J Med Genet 2003; 40:e96.
66. Hollenbach B, Morgenthaler NG, Struck J, et al. New assay for the measurement of selenoprotein P as a sepsis biomarker from serum. J Trace Elem Med Biol 2008; 22:24-32.
67. Carlson BA, Schweizer U, Perella C, et al. The selenocysteine t RNA STAF-binding region is essential for adequate selenocysteine t RNA status, seleno-protein expression and early age survival of mice. Biochem J2009; 418:61-71.
68. Burk RF, Hill KE, Olson GE, et al. Deletion of apolipoprotein E receptor-2 in mice lowers brain selenium and causes severe neurological dysfunction and death when a low-selenium diet is fed. J Neurosci 2007; 27:6207-6211. (Pubitemid 46890009)
69. Beffert U, Nematollah FF, Masiulis I, et al. Apo E receptor 2 controls neuronal survival in the adult brain. Curr Biol 2006; 16:2446-2452. (Pubitemid 44894907)